SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Pharma turning to injectable systems to protect biologics, says Unilife

22-Jan-2015 - Big Pharma firms like AbbVie are partnering with delivery device makers to guard against biosimilar competition according to Unilife CEO,  Alan Shortall.

Novozymes predicts half-life boost for pharma business, but lets long term rev forecast slide on oil prices

20-Jan-2015 - Novozymes finished 2014 with higher pharma revenues thanks in part to GSK's adoption of its albumin half-life extension technology, Veltis.

MannKind: Small step for delivery tech R&D after Afrezza's giant leap

19-Jan-2015 - MannKind’s development of new drugs with the delivery technology used in its inhalable insulin drug Afrezza will progress without founder Alfred Mann at the helm.

Capsugel buys ionic liquid tech IP to enhance lipid-based drug solubility

12-Jan-2015 - Capsugel has acquired a technology platform which uses ionic liquids to enhance the solubility of lipid-based drug delivery systems.

US pharmacy deals could cut costs of AbbVie and Gilead's HCV treatments

06-Jan-2015 - Gilead and AbbVie’s exclusive deals with payers CVS and Express Scripts could help cut the cost of the new class of treatments for America’s three million Hepatitis C sufferers.

India SRF buys DuPont's Dymel business and plans pharma plant

05-Jan-2015 - India SRF will set up a pharma-grade inhaler propellant manufacturing plant in India with tech and knowhow acquired from US chemical company DuPont.

In nano-rod we trust: magnetic pulse tech breakthrough for cancer drug delivery

17-Dec-2014 - A magnetic pulse technology that can align and push nanoparticles to points distant to magnet surfaces could finally make magnets attractive for deep tissue drug delivery according to researchers.

Sosei looks to $23bn peptide market with acquisition of tech firm Jitsubo

15-Dec-2014 - Sosei Group Corporation is looking to peptides to replenish its pipeline through the $70m acquisition of technology firm Jitsubo.

AstraZeneca shutting asthma drug plant as pipeline shifts to biologics

12-Dec-2014 - AstraZeneca has continued the Big Pharma trend away from small molecule blockbusters and towards a biologics-heavy pipeline, announcing the closure of its Pulmicort facility in Massachusetts.

Axim to build Dutch facility for cannabinoid-based chewing gum drug

04-Dec-2014 - A company developing a pharmaceutical chewing gum containing cannabinoids extracted from marijuana has announced plans to build a manufacturing facility in the Netherlands.

Investment in oral insulin firm could aid entry to lucrative China market

04-Dec-2014 - Oral insulin developer Oramed Pharmaceuticals is looking at China’s growing diabetes problem following a $5m investment from Guangxi Wuzhou Zhongheng.

Advanced aspirin aspirations ailing? Sanofi and Pozen terminate deal

02-Dec-2014 - Sanofi and Pozen have dissolved a $35m (Eur28m) ‘advanced aspirin’ partnership less than a month before the US Food and Drug Administration (FDA) decides whether to approve the new drug.

Happy Thanksgiving for GSK with FTC approval of Novartis vaccine biz

27-Nov-2014 - Just in time for the holidays, GSK can ‘give thanks’ to the US Federal Trade Commission (FTC) which has approved the $7bn acquisition of Novartis’ vaccine business.

Recipharm adds French plant and drug delivery tech in strategic deal with Flamel

27-Nov-2014 - Recipharm will acquire a facility and add technologies including spray granulation and spray coating as part of a “truly strategic” collaboration with France-based Flamel Technologies. 

Mind the gap: GSK and UK scientists say smaller is better for some biopharmaceuticals

19-Nov-2014 - UK researchers working with GSK say a newly identified immune cell communication mechanism could explain why some drugs don’t work and drive development of smaller, large molecule meds.

'Killer experiments' and reimbursement are the keys to VC backing says Index

17-Nov-2014 - Investors only back drug innovators because they have to according to Index Venture Management's Kevin Johnson, who says less risky 'first to be second' firms are much more attractive.

Actavis to acquire Botox maker Allergan for $66bn

17-Nov-2014 - After fending off hostile takeover bids from Valeant for nearly seven months, Allergan is finally agreeing to a takeover, but with Ireland-based Actavis.

AZ, ISIS expand partnership to develop novel delivery methods for antisense oligonucleotides

14-Nov-2014 - Isis Pharmaceuticals and AstraZeneca have expanded their partnership to develop novel delivery methods for antisense oligonucleotides in order to target the desired tissue more effectively. 

DISPATCHES FROM AAPS 2014

Ebola nasal vaccine under threat as funding runs dry

12-Nov-2014 - Lack of funding is threatening development of a nasal spray vaccine shown to provide long-term protection for non-human primates against the Ebola virus, the lead researcher told this publication in an exclusive interview.

Sanofi wearable injectable supply deal could net Unilife over $1bn per year

12-Nov-2014 - Unilife says its 15 year-wearable injector supply deal with Sanofi is “unprecendented” and could result in over $1bn of sales annually for the delivery device maker. 

UPDATE

Microneedles feasible peptide delivery tech, says Merck Director

11-Nov-2014 - Transdermal delivery using microneedles is an attractive and feasible administrative route for peptides, according to a Merck & Co. Director.

Inhalable insulin: Will Sanofi and MannKind succeed where Pfizer failed?

10-Nov-2014 - Afrezza will succeed where Pfizer's Exubera failed, say MannKind and Sanofi as they prepare to launch their inhalable insulin product.

Dispatches from AAPS

Inhaler delivered peptide could prevent LDC deaths during childbirth, says GSK

04-Nov-2014 - Inhaled delivery of the labour inducing peptide oxytocin could help prevent millions of deaths in the lesser-developed countries (LDC), according to a GSK scientist.

dispatches from AAPS

Breaking Ad: Can virus-delivered gene therapy help meth addicts quit?

04-Nov-2014 - Addicts struggling to kick a meth habit could be helped by gene therapy according to the team behind a US National Institutes of Health funded project.

Life on Mars? Ground control to remotely deliver drugs in space

30-Oct-2014 - Animal astronauts on the International Space Station will test an implant which allows doctors back on earth to deliver drugs by remote control.

Spotlight

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway
Competition

'On Immunity': enter BioPharma-Reporter.com’s free book giveaway

Did you know that throughout the nineteenth century, vaccination left a scar known as “the mark of...

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Illicit vendors using YouTube to advertise fake drugs, says MHRA

Regulatory enforcement saw fewer counterfeit drug websites in 2014 but sellers are turning to YouTube and social...

Resistance is…years away: New compound could delay post antibiotic era

Resistance is…years away: New compound could delay post antibiotic era

Discovering a new antibiotic candidate and finding out how it kills superbugs without letting resistant mutants escape...

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Oil's well that ends well? Low Brent crude price a boon for pharma says analyst

Falling oil prices will cut drug industry materials, manufacturing and logistics costs, and protect firms at risk...

Gilead strikes back at AbbVie with exclusive payer deal for hep C drug

US pharmacy deals could cut costs of AbbVie and Gilead's HCV treatments

Gilead and AbbVie’s exclusive deals with payers CVS and Express Scripts could help cut the cost of...

Not prepared for track & trace? US FDA grants amnesty until May

Not prepared for track & trace? US FDA grants amnesty until May

The US FDA will give drugmakers and distributors until May to comply with new track and trace...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...